0001209191-12-038459.txt : 20120718
0001209191-12-038459.hdr.sgml : 20120718
20120718154645
ACCESSION NUMBER: 0001209191-12-038459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120716
FILED AS OF DATE: 20120718
DATE AS OF CHANGE: 20120718
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12967934
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-07-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2012-07-16
4
M
0
6500
16.32
A
138816
D
Common Stock
2012-07-16
4
S
0
4000
52.49
D
134816
D
Common Stock
2012-07-16
4
S
0
2500
53.24
D
132316
D
Common Stock
4647
I
401(k)
Common Stock
15920
I
Common Stock held in trust.
Employee Stock Option Grant (right to buy)
16.32
2012-07-16
4
M
0
6500
0.00
D
2013-07-14
Common Stock
6500
29300
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $52.49 (range $51.91 to $52.88).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $53.24 (range $52.91 to $53.65).
Common stock held in grantor retained annuity trusts.
Fully vested.
Valerie L. Andrews, Attorney-In-Fact
2012-07-18